PRA Health Sciences Inc (PRAH):企業の財務・戦略的SWOT分析

◆英語タイトル:PRA Health Sciences Inc (PRAH) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH6084FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥66,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥99,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
PRA Health Sciences Inc (PRA) is a contract research organization (CRO) which provides outsourced clinical development and data solution services. The company offers asset valuation, regulatory and drug development consulting, risk-based monitoring, site identification and selection, medical writing, validation, commercialization, data management, statistical analysis, clinical pharmacology and other services. It provides services in the therapeutic areas of oncology, immunology, central nervous system, inflammation, respiratory, cardiometabolic and infectious diseases. PRA serves pharmaceutical and biotechnology industries. The company has operations across North and Latin America, Europe, Asia, South Africa, Australia and the Middle East. PRA is headquartered in Raleigh, North Carolina, the US.

PRA Health Sciences Inc Key Recent Developments

Apr 08,2021: Platform pemantauan pesakit jarak jauh PRA dipilih oleh Merck KGaA, Darmstadt, Germany untuk digunakan dalam gabungan dengan sistem rawatan hormon pertumbuhan manusia miliknya
Apr 07,2021: PRA’s remote patient monitoring platform selected by Merck KGaA, Darmstadt, Germany to work in combination with its human growth hormone treatment system
Mar 23,2021: PRA Health Sciences introduces Patient-Centric Trial Development Toolkit
Feb 24,2021: Ireland’s ICON signs agreement to acquire PRA Health Sciences

This comprehensive SWOT profile of PRA Health Sciences Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of PRA Health Sciences Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

PRA Health Sciences Inc – Key Information
PRA Health Sciences Inc – Overview
PRA Health Sciences Inc – Key Employees
PRA Health Sciences Inc – Key Employee Biographies
PRA Health Sciences Inc – Key Operational Heads
PRA Health Sciences Inc – Major Products and Services
PRA Health Sciences Inc – History
PRA Health Sciences Inc – Company Statement
PRA Health Sciences Inc – Locations And Subsidiaries
PRA Health Sciences Inc
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

PRA Health Sciences Inc – Business Description
PRA Health Sciences Inc – Corporate Strategy
PRA Health Sciences Inc – SWOT Analysis
SWOT Analysis – Overview
PRA Health Sciences Inc – Strengths
PRA Health Sciences Inc – Weaknesses
PRA Health Sciences Inc – Opportunities
PRA Health Sciences Inc – Threats
PRA Health Sciences Inc – Key Competitors

Section 3 – Company Financial Performance Charts

PRA Health Sciences Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

PRA Health Sciences Inc, Key Information
PRA Health Sciences Inc, Key Ratios
PRA Health Sciences Inc, Share Data
PRA Health Sciences Inc, Major Products and Services
PRA Health Sciences Inc, History
PRA Health Sciences Inc, Key Employees
PRA Health Sciences Inc, Key Employee Biographies
PRA Health Sciences Inc, Key Operational Heads
PRA Health Sciences Inc, Other Locations
PRA Health Sciences Inc, Subsidiaries
PRA Health Sciences Inc, Key Competitors
PRA Health Sciences Inc, SWOT Analysis
PRA Health Sciences Inc, Ratios based on current share price
PRA Health Sciences Inc, Annual Ratios
PRA Health Sciences Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[PRA Health Sciences Inc (PRAH):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Prologis Inc (PLD):企業の財務・戦略的SWOT分析
    Prologis Inc (PLD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • North Pacific Bank,Ltd:企業の戦略・SWOT・財務情報
    North Pacific Bank,Ltd - Strategy, SWOT and Corporate Finance Report Summary North Pacific Bank,Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Betta Pharmaceuticals Co Ltd (300558):製薬・医療:M&Aディール及び事業提携情報
    Summary Betta Pharmaceuticals Co Ltd (Betta Pharma) is a pharmaceutical company that researches, develops, manufactures and markets drugs for the treatment of cancer, cardiovascular diseases and diabetes. The company offers icotinib hydrochloride, an orally administered small-molecule, reversible ty …
  • Acarix AS:医療機器:M&Aディール及び事業提携情報
    Summary Acarix A/S (Acarix) is a medical device company that provides design and development of non-invasive cardiac screening products. The company provides non-invasive screening device, CADScor system used to record, process and display heart signals as a patient specific score as the CAD-score o …
  • Regulus Therapeutics Inc (RGLS):製薬・医療:M&Aディール及び事業提携情報
    Summary Regulus Therapeutics Inc (Regulus Therapeutics) is a biopharmaceutical company that discovers and develops microRNA based therapeutics. The company provides single stranded oligonucleotides, which are chemically synthesized chains of nucleotides that are mirror images of specific target micr …
  • Teledyne Technologies Inc (TDY):企業の財務・戦略的SWOT分析
    Teledyne Technologies Inc (TDY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • NovioSense BV-医療機器分野:企業M&A・提携分析
    Summary NovioSense BV (NovioSense) is a medical device company that develops a wireless technology platform for non-invasive monitoring of disease biomarkers. The company provides NovioSense, a glucose sensor to continuously monitor glucose levels in the tear fluid and sends a wireless signal to a h …
  • Shanghai Fosun Pharmaceutical (Group) Co Ltd (600196):企業の財務・戦略的SWOT分析
    Summary Shanghai Fosun Pharmaceutical (Group) Co Ltd (Fosun Pharma), a subsidiary of Shanghai Fosun High Technology (Group) Co Ltd is a drug company that offers pharmaceutical products, medical diagnostic products and medical device products. The company’s pharmaceutical products include metabolism …
  • Alfresa Holdings Corp (2784):製薬・医療:M&Aディール及び事業提携情報
    Summary Alfresa Holdings Corp (Alfresa) is a manufacturer and marketer of pharmaceuticals, diagnostic reagent and medical devices. The company offers ethical pharmaceuticals wholesaling, self-medication products and manufacturing. It’s ethical pharmaceutical wholesaling business supplies diagnostic …
  • Idera Pharmaceuticals Inc (IDRA):製薬・医療:M&Aディール及び事業提携情報
    Summary Idera Pharmaceuticals Inc. (Idera) is a clinical stage biopharmaceutical company, which focuses on the discovery, development and commercialization of drugs for the treatment of cancer and rare diseases. It develops DNA and RNA based drug candidates aimed at toll-like receptors (TLR) for the …
  • Altacor Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Altacor Ltd (Altacor) is an ophthalmology company that develops and markets orphan products for chronic eye conditions. The company offers prescription and retail ophthalmology products. Its products include dry eye prescription products; dry eye retail products; products for the treatment o …
  • Uni-President China Holdings Ltd:企業の戦略・SWOT・財務分析
    Uni-President China Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Uni-President China Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Starwood Property Trust Inc:企業のM&A・事業提携・投資動向
    Starwood Property Trust Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Starwood Property Trust Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • DaVita Inc (DVA):企業の財務・戦略的SWOT分析
    DaVita Inc (DVA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • The Quaker Oats Company:企業の戦略・SWOT・財務情報
    The Quaker Oats Company - Strategy, SWOT and Corporate Finance Report Summary The Quaker Oats Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Brunei LNG Sdn Bhd:企業の戦略的SWOT分析
    Brunei LNG Sdn Bhd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Avanti Feeds Ltd (AVANTIFEED):企業の財務・戦略的SWOT分析
    Avanti Feeds Ltd (AVANTIFEED) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Sonic Healthcare Limited:企業のM&A・事業提携・投資動向
    Sonic Healthcare Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Sonic Healthcare Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • Collagen Solutions Plc (COS)-医療機器分野:企業M&A・提携分析
    Summary Collagen Solutions Plc (Collagen Solutions), formerly Healthcare Investment Opportunities Plc is a medical device company that develops, manufactures and supplies medical grade collagen biomaterials and components. The company offers sourcing and supply of high grade collagen; provision of f …
  • Xped Ltd (XPE):企業の財務・戦略的SWOT分析
    Xped Ltd (XPE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆